These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23535059)

  • 1. Cost as a barrier to long-acting reversible contraceptive (LARC) use in adolescents.
    Eisenberg D; McNicholas C; Peipert JF
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S59-63. PubMed ID: 23535059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review.
    Birgisson NE; Zhao Q; Secura GM; Madden T; Peipert JF
    J Womens Health (Larchmt); 2015 May; 24(5):349-53. PubMed ID: 25825986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual use of long-acting reversible contraceptives and condoms among adolescents.
    Williams RL; Fortenberry JD
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S29-34. PubMed ID: 23535054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
    Broecker J; Jurich J; Fuchs R
    Contraception; 2016 Mar; 93(3):266-72. PubMed ID: 26577755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Meeting the contraceptive needs of teens and young adults: youth-friendly and long-acting reversible contraceptive services in U.S. family planning facilities.
    Kavanaugh ML; Jerman J; Ethier K; Moskosky S
    J Adolesc Health; 2013 Mar; 52(3):284-92. PubMed ID: 23298980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attitudes toward long-acting reversible contraception among young women seeking abortion.
    Rose SB; Cooper AJ; Baker NK; Lawton B
    J Womens Health (Larchmt); 2011 Nov; 20(11):1729-35. PubMed ID: 21923281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-acting reversible contraception (LARC) use among adolescent females in secondary institutions in Nnewi, Nigeria.
    Eke AC; Alabi-Isama L
    J Obstet Gynaecol; 2011; 31(2):164-8. PubMed ID: 21281035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Committee opinion no. 539: adolescents and long-acting reversible contraception: implants and intrauterine devices.
    Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group, The American College of Obstetricians and Gynecologists
    Obstet Gynecol; 2012 Oct; 120(4):983-8. PubMed ID: 22996129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness of long-acting reversible contraception among teens and young adults.
    Teal SB; Romer SE
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S35-9. PubMed ID: 23535055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current challenges in contraception in adolescents and young women.
    Cornet A
    Curr Opin Obstet Gynecol; 2013 Mar; 25 Suppl 1():S1-10. PubMed ID: 23370330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies to prevent unintended pregnancy: increasing use of long-acting reversible contraception.
    Blumenthal PD; Voedisch A; Gemzell-Danielsson K
    Hum Reprod Update; 2011; 17(1):121-37. PubMed ID: 20634208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.
    Garrett CC; Keogh LA; Kavanagh A; Tomnay J; Hocking JS
    BMC Womens Health; 2015 Sep; 15():72. PubMed ID: 26359250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Teen pregnancy prevention on a LARC: an update on long-acting reversible contraception for the primary care provider.
    Dodson NA; Gray SH; Burke PJ
    Curr Opin Pediatr; 2012 Aug; 24(4):439-45. PubMed ID: 22732635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers and Facilitators to Adolescents' Use of Long-Acting Reversible Contraceptives.
    Pritt NM; Norris AH; Berlan ED
    J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):18-22. PubMed ID: 27477904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Providing long-acting reversible contraception services in Seattle school-based health centers: key themes for facilitating implementation.
    Gilmore K; Hoopes AJ; Cady J; Amies Oelschlager AM; Prager S; Vander Stoep A
    J Adolesc Health; 2015 Jun; 56(6):658-65. PubMed ID: 26003582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of long-acting reversible contraception on rapid repeat pregnancy in adolescents: a review.
    Baldwin MK; Edelman AB
    J Adolesc Health; 2013 Apr; 52(4 Suppl):S47-53. PubMed ID: 23535057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Barriers to Health Care Providers' Provision of Long-Acting Reversible Contraception to Adolescent and Nulliparous Young Women.
    Hopkins B
    Nurs Womens Health; 2017; 21(2):122-128. PubMed ID: 28388997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IUDs and adolescents--an under-utilized opportunity for pregnancy prevention.
    Yen S; Saah T; Hillard PJ
    J Pediatr Adolesc Gynecol; 2010 Jun; 23(3):123-8. PubMed ID: 19896396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Latest in Teen Pregnancy Prevention: Long-Acting Reversible Contraception.
    McClellan K; Temples H; Miller L
    J Pediatr Health Care; 2018; 32(5):e91-e97. PubMed ID: 30180941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-acting reversible contraception: a practical solution to reduce unintended pregnancy.
    Secura G
    Minerva Ginecol; 2013 Jun; 65(3):271-7. PubMed ID: 23689169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.